Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPLIT trial of saline versus Plasma-Lyte 148 in ICU fluid therapy
ACTRN12613001370796Phase 3Completed
- Sponsor
- Medical Research Institute of New Zealand
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of sodium chloride and plasma-lyte in critical illness (2 arms), sponsored by Medical Research Institute of New Zealand. Primary endpoint: Proportion of patients with acute kidney injury or failure by RIFLE creatinine criteria. Started Apr 2014; status: completed.
02
Drugs
sodium chlorideplasma-lyte
03
Conditions
critical illness
Beyond the preview
Go deeper on ACTRN12613001370796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12613001370796.